Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01719Pentazocine hydrochloride--
BADD_D01720Pentazocine lactate--
BADD_D01725Pentetreotide--
BADD_D01730Pentostatin--
BADD_D01731Pentoxifylline0.007813%
BADD_D01733Perampanel--
BADD_D01734Perflutren--
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
BADD_D01737Perhexiline--
BADD_D01739Perindopril--
BADD_D01740Perindopril erbumine--
BADD_D01741Perindoprilat--
BADD_D01744Pertuzumab--
BADD_D01750Phenelzine--
BADD_D01751Phenelzine sulfate--
BADD_D01752Phenobarbital--
BADD_D01754Phenoxybenzamine--
BADD_D01756Phentermine--
BADD_D01758Phentolamine--
BADD_D01759Phentolamine mesylate--
BADD_D01761Phenylcyclopropan-1-amine;sulfuric acid--
BADD_D01765Phenytoin--
BADD_D01767Phosphonatoformate--
BADD_D01771Pilocarpine hydrochloride--
BADD_D01774Pimozide--
BADD_D01776Pindolol--
BADD_D01777Pioglitazone--
BADD_D01779Piperacillin--
BADD_D01781Pirbuterol--
The 32th Page    First    Pre   32 33 34 35 36    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target